Cargando…
Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer
The high rates of tumor recurrence and progression represent a major clinical problem in non-muscle invasive bladder cancer. Previous data showed that EZH2-dependent signaling mediates these processes, whereas the frequent alterations of PIK3CA gene (copy gains and mutations) are predictive of reduc...
Autores principales: | Segovia, Cristina, Martínez-Fernández, Mónica, Dueñas, Marta, Rubio, Carolina, López-Calderón, Fernando F., Costa, Clotilde, Saiz-Ladera, Cristina, Fernández-Grajera, María, Duarte, José, García Muñoz, Huberto, de la Rosa, Federico, Villacampa, Felipe, Castellano, Daniel, Paramio, Jesús M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354678/ https://www.ncbi.nlm.nih.gov/pubmed/28060766 http://dx.doi.org/10.18632/oncotarget.14453 |
Ejemplares similares
-
EZH2 in Bladder Cancer, a Promising Therapeutic Target
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015) -
Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015) -
A Polycomb-mir200 loop regulates clinical outcome in bladder cancer
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015) -
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
por: Martinez, Victor G., et al.
Publicado: (2019) -
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring
por: Lodewijk, Iris, et al.
Publicado: (2018)